Levels of apoproteins B, A1 and CIII as markers for cardiovascular risk in lean and obese adolescents;Niveles de apoproteínas B, A1 y CIII como marcadores de riesgo cardiovascular en adolescentes delgados y obesos

Investigacion Clinica

Volumn 45, Issue 1, 2004, Pages 29-42

  Fernández, Virginia ^a   Morales, Luz Marina ^a   Molero Conejo, Emperatriz ^a   Casanova, Ángel ^a   Campos, Gilberto ^a   Raleigh, Xiomara ^a   Gómez, María Esther ^a   Ryder, Elena ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Adolescents; Apolipoproteins; Insulin resistance; Obesity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IMMUNOASSAY; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; BIOLOGICAL MARKERS; BODY WEIGHT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS;

EID: 1942437580     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ginsberg HN. Lipoprotein physiology Endocrinol Metab Clin North Am 1998; 27(3):503-19.
2. Packard CJ, Shepherd J. Lipoprotein heterogeneeity and apolipoprotein B metabolism. Atheroseler Thromb Vase Biol 1997; 17:3542-3556.
3. Packard OJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schewelfeger G, Bedynek A. Metabolism and the distribution of VLDL and LDL subfraction. J Lipid Res 2000; 41:305-317.
4. Antwerpen R, La Belle M, Navratilova E, Krauss R. Structural heterogeneity of apo B containing serum lipoprotein visualized using cryo-electron microscopy. J Lipid Res 1999; 40:1827-1836.
5. Campos H, Arnold KS, Balestra ME, Innerariry TH, Krauss RM. Differences in receptor binding of LDL subfraction. Ateroscler Thromb Vase Biol 1999; 16:794-801.
6. Krauss R, Blanche P. Detection and quantitation of LDL subfraction. Curr Open Lipidol 1992; 3:377-383.
7. Stanfer MJ, Sacks FM, Salvene S, Willet WC, Henekens CH. A prospective study of cholesterol, apolipoproteins and risk of myocardial infarction. N Engl J Med 1991; 325:373-381.
8. Susuki N, Fidge N, Nestel P, Yin J. Interaction of serum lipoproteins with the intestine evidence for specific high density lipoprotein - binding sites of isolated rat intestinal mucosal cell. J Lipid Res 1983; 24:253-264.
9. Reaven GM, CIIen YD, Leppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinaemia in individuals with small dense low density lipoproteins particles. J Clin Invest 1993; 92:141-142.
10. Wilson PW, D'Agostino B, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
11. Segrest JP, Jones MK, De Loor H, Browllette C, Venkalachalopathi YV, Anantharamarah GM. The amphipatic helix in the exchangeble apolipoprotein: a review of secondary structural and function. J Lipid Res 1992; 33:141-166.
12. Assmann G, Sehulte H. Relation of high-density lipoprotein cholesterol triglycerides to incidence of atherosclerosis coronary artery disease (The PROCAM experience). Prospective Cardiovascular Munter Study. Am J Cardiol 1992; 70:733-737.
13. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1974; 1:16-20.
14. 1 is no associated with increased susceptibility to atherosclerosis in mice. Arteroesel Thromb 1993; 13:1814-1821.
15. Hirano K, Yamashita S, Kuga Y, Sakai N, Nosaki Skyhara S, Arai T, Yanagi K, Takami S, Menju M. Atherosclerosis disease in marked hyper alphalipoproteinemia combined reduction of cholesteryl ester tranfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vase Biol 1995; 15(11):1849-1856.
16. Oram JF, Yokoyama S. Apolipoprotein mediated removal of celular cholesterol and phospholipids. J Lipid Res 1996; 37: 2473-2491.
17. Hara H, Hara H, Komaba A, Yokoyama S. α Helicoidal requirements for free apolipoproteins to generate HDL and to induce celular lipid efflux. Lipid 1992; 27: 302-304.
18. Lue G, Bard JM, Ferrieres J, Evans A, Amouyel P, Arveiler D. Values of HDL Cholesterol, Apolipoprotein A1, and Lipoprotein A1, and Lipoprotein A1/A1I in Prediction of Coronary Heart Disease. THE PRIME Study. Atheroseler Thromb Vase Biol 2002; 22 (7):1155-1160
19. Fredenvinch A, Giroux LM, Tremblay M, Krimbou L, Davignon J, Chohm J. Plasma lipoprotein distribution of apo C III in normolipemic and hipertriglyceridemic subjects: comparison of the apo C III to apo E ratio in different lipoprotein fraction. J Lipid Res 1997; 38:1421-1432.
20. Windler E, Havel RJ. Inhibitor effect of C apolipoproteins from rats and humans on the uptake of triglyceride - rich lipoproteins and their remmants by the perfused rat liver. J Lipid Res 1985; 26: 556-563.
21. Wang CS, Me Conathy WJ, Kloer HU, Alaupovie P. Modulation of lipoprotein lipase by apolipoproteins: effect of apolipoproteins C III. J Clin Invest 1985; 75:384-390.
22. Clavey M, Lestavel-Delattol S, Copen C, Bard JM, Fruehart JC. Modulation of lipoprotein B binding to the LDL receptor by exogenus lipids and apolipoprotein C I, CII, C III and E. Atheroscler Thromb Vase Biol 1995; 15:963-971.
23. Florez H, Mendez A, Jones L, Goldberg R. Diferencias según sexo y estado diabético en la relación apoproteína C III y ácidos grasos libres con los triglicéridos sérieos en sujetos a riesgo para intolerancia a la glucosa. Invest Clin 1999; 40(3):51-66.
24. Petrovani R, Coman AE, Hurjui J. Apolipoprotien a cardiovascular risk factor within the context of syndrome X. Rev Med Cher Soc Med Nat Iasi 1996; 100(1-2): 136-138.
25. Okata T, Sato Y, Yamazaki H, Fwata F, Hara M, Misawa M, Kim H, Noto N, Harada K, Ryo S. Relationship between fat distribution and lipid and apolipoproteins profiles in young teenagers. Acta Paediatr Jpn 1997; 40(1):35-40.
26. Bertiere MC, Fumeron F, Regaud D, Apfelbaum M, Guard-Globa A. Low high density lipoproteins 2 concentration in obese male subjects. Atherosclerosis 1988; 73:57-61.
27. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Coexistance of severe insulin resistance and hyperinsulinaemia in preadolescent obese children. Diabetologia 1996; 39:1489-1497.
28. Morrison JA, Barton BA, Biro FM, Sprecher DL. The conjoint trait of low high - density lipoprotein cholesterol and high triglycerides in adolescents black and whites males. Metabolism 1998; 47(5):514-521.
29. Moussa MA, Shaltout AA, NKansa-Dwanema D, Mourad M. Apolipoproteins A1 and B in Kuwait children. Ann Nutr Metab, 1998; 42(4):202-210.
30. rd, Freedman DG, Voors AW, Srinivasan SR, Cresanta JL, Willianson G, Weber LS, Berenson GS. Relation of serum lipoprotein level and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study N Engl J Med 1996; (3):314:138-144.
31. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlic PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoproteins (a), apolipoproteins A1, and B, and HDL density subfractions The Atherosclerosis Risk in Communities Study Group. Circulation 2001; 104: 1108-1113.
32. Srinivasan SR, Berenson GS. Childhood lipoprotein profiles and implication for adult coronary artery disease: The Bogalusa Heart Study. Am J Med Sci 1995; 310(Suppl 1):S62-S67.
33. Falkner B, Hassink S, Ross J, Gidding S. Dysmetabolic Syndrome: Multiple Risk Factor for Premature Adult Disease in an Adolescent Girl. Pediatrics 2002; 1:110.
34. nd ed Oxford: Blackwell Scientific Publications; 1962.
35. Haffner S, Miettinen H, Stern M. The Homeostasis model in the San Antonio Study. Diabetes Care 1997; 20:1087-1092.
36. Molero-Conejo E, Morales LM, Fernández V, Raleigh X, Semprum-Fereira M, Gómez ME, Campos G, Ryder E. Lean Adolescents with increased risk for Metabolic Syndrome. Arch Latinoamer Nutr 2003; 53:(1):39-46.
37. Svege T, Fex G. Apolipoprotein A1 and B levels in adolescents; a trial to define subjects at risk for coronary heart disease. Acta Paedriatr Scand 1983; 72(4):499-504.
38. Bahorick PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and A1 distributions in the United States, 1998-1991: results of the National Health and Nutrition Examination Survey III (NHANES III) Clin Chem 1997; 43 (1): 2364-2378.
39. Zunic G, Jelie-Ivanoevie I, Spasic S, Stojiljkovie A, Majkie-Singh N. Reference values for apolipoprotein A1 and B in healthy subjects, by age. Clin Chem 1992; 38 (4):566-569.
40. Ohta T, Saku K, Nakamura R, Hamhung KK, Matsuda I. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels. Atherosclerosis 1998; 137(2): 321-328.
41. Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais G, Lupien P, Després J. Influence of Triglyceride Concentrations on the Relationship Between Lipoprotein Cholesterol and Apolipoprotein B and A1 Levels. Metabolism 2000; 49:(1) 53-61.
42. Goldberg IJ. Lipoprotein lipase and lipolysis central roles in lipoprotein metabolism and atherosclerosis. J Lipid Res 1996; 37:693-707.
43. Bergströn E, Hernell O, Persson LA, Vessby B. Insulin resistance syndrome in adolescents. Metabolism 1996; 45 (7):908-914.
44. National Institute of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) 2001. Washington, DC, US Govt. Printing Office, (NIH publ. No. 01-3670).
45. Odeleye O, De Courten M, Pettitt D, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weigth gain and obesity in Pima Indians Children. Diabetes 1997; 46:1341-1345.
46. Moussa MA, Shaltout AA, Nkansa-Dwamena D, Mourad M, Al-Sheikh N, Agha N, Galai DO. Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children. Metabolism 1998; 47(4):420-424.
47. Mykkänen L, Kuusisto J, Haffner S, Pyörälä K, Laakso M. Hyperinsulinemia Predicts Multiple Atherogenie Changes in lipoproteins in Elderly Subjects. Arterioscler Thromb 1994; 14:518-526.